About: Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice. Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Erlotinib is a low molecular weight inhibitor of tyrosine kinase receptor for epidermal growth factor. In clinical practice it is used for the treatment of advanced stages of NSCLC. Papulopustular rash (rash) is the most common manifestation of erlotinib skin toxicity. Poster presenting the data from analysis represents the occurrence of rash as a predictor of treatment effect of erlotinib in patients carrying the wild-type EGFR and KRAS wild-type genes and assessment of its possible use in clinical practice. Erlotinib is a low molecular weight inhibitor of tyrosine kinase receptor for epidermal growth factor. In clinical practice it is used for the treatment of advanced stages of NSCLC. Papulopustular rash (rash) is the most common manifestation of erlotinib skin toxicity. Poster presenting the data from analysis represents the occurrence of rash as a predictor of treatment effect of erlotinib in patients carrying the wild-type EGFR and KRAS wild-type genes and assessment of its possible use in clinical practice. (en)
Title	Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice. Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice. (en)
skos:prefLabel	Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice. Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice. (en)
skos:notation	RIV/26475821:_____/12:#0000137!RIV12-MZ0-26475821
http://linked.open...avai/riv/aktivita	P
http://linked.open...avai/riv/aktivity	P(NS9718)
http://linked.open...vai/riv/dodaniDat	2012
http://linked.open...aciTvurceVysledku	Minárik, Marek Benešová, Lucie
http://linked.open.../riv/druhVysledku	O - Ostatní výsledky nezařaditelné do žádného z výše uvedených druhů výsledku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Genomac International, s.r.o.
http://linked.open...dnocenehoVysledku	168240
http://linked.open...ai/riv/idVysledku	RIV/26475821:_____/12:#0000137
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	NSCLC; skin rash; erlotinib (en)
http://linked.open.../riv/klicoveSlovo	skin rash NSCLC erlotinib
http://linked.open...ontrolniKodProRIV	[128CD0CAF5B8]
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	2 (xsd:int)
http://linked.open...cetTvurcuVysledku	8 (xsd:int)
http://linked.open...vavai/riv/projekt	New possibilities for application of molecular-diagnostic methods for early detection and proper therapy selection of progressing Non-Small Cell Lung Cancer based on detection and monitoring of hypermethylation of specific genes
http://linked.open...UplatneniVysledku	2012
http://linked.open...iv/tvurceVysledku	Benšová, Lucie Minárik, Marek

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software